Born out of a need to translate Virginia Tech research to commercial potential, the Virginia Tech Corporate Research Center has been a pipeline for research since 1985. As we observe National Kidney Month in March, we wanted to thank the researchers and scientists on our campus who are conducting critical research and finding solutions so we can live better lives.
Medical studies over the past 40 years have shown that many forms of kidney disease are progressive, potentially leading to end-stage kidney disease and renal failure. These studies have also shown that early detection of chronic kidney disease (CKD) and the use of medical and lifestyle interventions may slow the progression of CKD and reduce associated healthcare costs, which approach $34B annually (about 15% of the Medicare budget).
DialySensors, Inc. is a healthcare technology company co-founded by Drs. John Robertson and Ryan Senger, the inventors of the Rametrix™ technology. The company collaborates with nephrologists, urologists, surgeons, oncologists, and other healthcare professionals on numerous ongoing proof-of-concept and validation studies in academic, corporate, and government settings.
The shared goal of the DialySensors team and their collaborators is to use Rametrix™ technology to improve patient care and quality of life – with fast and inexpensive screening to identify chronic kidney disease (CKD) in early stages and monitor treatment efficacies.
The #VTCRCexperience provides companies like DialySensors a collaborative ecosystem and state-of-the-art labs so they in turn can make 10x impact.